Literature DB >> 22126602

Y654 of β-catenin is essential for FLT3/ITD-related tyrosine phosphorylation and nuclear localization of β-catenin.

Tomohiro Kajiguchi1, Akira Katsumi, Ryohei Tanizaki, Hitoshi Kiyoi, Tomoki Naoe.   

Abstract

β-Catenin plays a dual role as a key effecter in the regulation of adherens junctions as well as a transcriptional co-activator. Tyrosine phosphorylation of β-catenin affects the cell adhesion, migration, and gene transcription in many types of human cancer cells, including acute myeloid leukemia cells with FLT3 internal tandem duplication (FLT3/ITD-AML). Here, we investigated the relationship between three tyrosine residues (Y86, Y142, and Y654) in β-catenin and oncogenic FLT3/ITD kinase. In the experiments using COS-7 cells expressing FLT3/ITD and Wt or mutant β-catenin, FLT3/ITD phosphorylated Y654, and this residue was essential for β-catenin's nuclear localization by FLT3/ITD. Promoter-reporter assays demonstrated that Y654 phosphorylation of β-catenin was closely related to TCF transcriptional activity. In vitro kinase assays, using recombinant FLT3 and biotinylated β-catenin peptide including Y654 showed that FLT3 directly phosphorylated Y654 of β-catenin. These results explain how FLT3/ITD affects the tyrosine phosphorylation, nuclear localization, and transcriptional activity of β-catenin. Targeting Y654 phosphorylation may lead to the development of novel approaches to therapy for FLT3/ITD-AML.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22126602     DOI: 10.1111/j.1600-0609.2011.01738.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  19 in total

1.  Targeting nuclear β-catenin as therapy for post-myeloproliferative neoplasm secondary AML.

Authors:  Dyana T Saenz; Warren Fiskus; Taghi Manshouri; Christopher P Mill; Yimin Qian; Kanak Raina; Kimal Rajapakshe; Cristian Coarfa; Raffaella Soldi; Prithviraj Bose; Gautam Borthakur; Tapan M Kadia; Joseph D Khoury; Lucia Masarova; Agnieszka J Nowak; Baohua Sun; David N Saenz; Steven M Kornblau; Steve Horrigan; Sunil Sharma; Peng Qiu; Craig M Crews; Srdan Verstovsek; Kapil N Bhalla
Journal:  Leukemia       Date:  2018-12-21       Impact factor: 11.528

2.  The Role of Wnt/β-Catenin Signaling and K-Cadherin in the Regulation of Intraocular Pressure.

Authors:  Hannah C Webber; Jaclyn Y Bermudez; J Cameron Millar; Weiming Mao; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-03-01       Impact factor: 4.799

Review 3.  Can we safely target the WNT pathway?

Authors:  Michael Kahn
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

4.  A conserved phosphorylation switch controls the interaction between cadherin and β-catenin in vitro and in vivo.

Authors:  Hee-Jung Choi; Timothy Loveless; Allison M Lynch; Injin Bang; Jeff Hardin; William I Weis
Journal:  Dev Cell       Date:  2015-04-06       Impact factor: 12.270

5.  Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in FLT3-Mutant Acute Myeloid Leukemia.

Authors:  Xuejie Jiang; Po Yee Mak; Hong Mu; Wenjing Tao; Duncan H Mak; Steven Kornblau; Qi Zhang; Peter Ruvolo; Jared K Burks; Weiguo Zhang; Teresa McQueen; Rongqing Pan; Hongsheng Zhou; Marina Konopleva; Jorge Cortes; Qifa Liu; Michael Andreeff; Bing Z Carter
Journal:  Clin Cancer Res       Date:  2018-02-20       Impact factor: 12.531

Review 6.  Role and regulation of β-catenin signaling during physiological liver growth.

Authors:  Satdarshan Paul Singh Monga
Journal:  Gene Expr       Date:  2014

7.  β-catenin contributes to lung tumor development induced by EGFR mutations.

Authors:  Sohei Nakayama; Natasha Sng; Julian Carretero; Robert Welner; Yuichiro Hayashi; Mihoko Yamamoto; Alistair J Tan; Norihiro Yamaguchi; Hiroyuki Yasuda; Danan Li; Kenzo Soejima; Ross A Soo; Daniel B Costa; Kwok-Kin Wong; Susumu S Kobayashi
Journal:  Cancer Res       Date:  2014-08-27       Impact factor: 12.701

8.  β-catenin signaling in murine liver zonation and regeneration: a Wnt-Wnt situation!

Authors:  Jing Yang; Laura E Mowry; Kari Nichole Nejak-Bowen; Hirohisa Okabe; Cassandra R Diegel; Richard A Lang; Bart O Williams; Satdarshan P Monga
Journal:  Hepatology       Date:  2014-07-25       Impact factor: 17.425

Review 9.  Wnt/beta-catenin signaling and small molecule inhibitors.

Authors:  Andrey Voronkov; Stefan Krauss
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

10.  γ-Catenin is overexpressed in acute myeloid leukemia and promotes the stabilization and nuclear localization of β-catenin.

Authors:  R G Morgan; L Pearn; K Liddiard; S L Pumford; A K Burnett; A Tonks; R L Darley
Journal:  Leukemia       Date:  2012-08-03       Impact factor: 11.528

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.